文献速递血栓与止血造血干细胞移植与细胞治疗

急性血小板减少症中造血干细胞应答需要不同受体酪氨酸激酶信号传导

Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases.
PubMed 文献 · Blood · 2019-08-21

该研究利用小鼠急性血小板减少症模型,探究造血干细胞与龛细胞在血小板池恢复过程中的相互作用。研究发现该过程需要巨核细胞中膜定位的干细胞因子(m-SCF),其受VEGF-A和PDGF-BB调控;HSC和MPP2而非MPP3/4通过m-SCF/c-Kit和VEGF-A/VEGFR-2双受体酪氨酸激酶依赖信号被激活,促进其选择性早期增殖。

要点

  • 急性血小板减少症恢复需要巨核细胞膜定位干细胞因子(m-SCF)。
  • m-SCF受VEGF-A和PDGF-BB调控。
  • HSC和MPP2而非MPP3/4通过m-SCF/c-Kit和VEGF-A/VEGFR-2双RTK信号选择性早期增殖。

核心结论

  • 急性血小板减少症恢复过程中,HSC和MPP2的选择性早期激活依赖于m-SCF/c-Kit和VEGF-A/VEGFR-2双受体酪氨酸激酶信号。

研究设计与样本

  • 研究采用小鼠急性血小板减少症模型,探究HSC与龛细胞在血小板池恢复过程中的相互作用。

主要发现

  • 血小板池恢复过程需要巨核细胞中膜定位的干细胞因子(m-SCF)。
  • m-SCF受VEGF-A和PDGF-BB调控。
  • HSC和MPP2而非MPP3/4通过m-SCF/c-Kit和VEGF-A/VEGFR-2双受体酪氨酸激酶依赖信号被激活,促进其选择性早期增殖。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although bone marrow niche cells are essential for hematopoietic stem cell (HSC) maintenance, their interaction in response to stress is not well defined. Here, we used a mouse model of acute thrombocytopenia to investigate the cross talk between HSCs and niche cells during restoration of the thrombocyte pool. This process required membrane-localized stem cell factor (m-SCF) in megakaryocytes, which was regulated, in turn, by vascular endothelial growth factor A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB). HSCs and multipotent progenitors type 2 (MPP2), but not MPP3/4, were subsequently activated by a dual-receptor tyrosine kinase (RTK)-dependent signaling event, m-SCF/c-Kit and VEGF-A/vascular endothelial growth factor receptor 2 (VEGFR-2), contributing to their selective and early proliferation. Our findings describe a dynamic network of signals in response to the acute loss of a single blood cell type and reveal the important role of 3 RTKs and their ligands in orchestrating the selective activation of hematopoietic stem and progenitor cells (HSPCs) in thrombocytopenia.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Ramasz B, Krüger A, Reinhardt J, et al. Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases. Blood. 2019. PMID: 31434705. doi:10.1182/blood.2019000721

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。